During the early stages of our project, the entire HP team held a meeting to tackle two important questions: how our project would impact society and how these societal factors would shape the trajectory of our project.

Figure 1: Brainstorming Session.

Confined to a strict timeline, we recognised the need to begin by identifying and categorising our stakeholders into two primary groups: quantitative and qualitative. The quantitative stakeholders encompass individuals who possess expertise and knowledge that can impact the design and experimental process in our product including academia professors, doctors, nutritionists and pharmaceutical companies. On the other hand, the qualitative stakeholders consist of those that would be directly affected by our product, mostly patients who have had negative experiences with existing medications for high cholesterol as well as individuals at risk of developing high cholesterol. Lastly we recognised that in order for us to learn from all the encounters we would have, we would need to reflect on them. We analysed the different models of reflection and settled on Kolb's Learning Cycle Development as a way to consciously explore our experiences.

Figure 2: Kolb's Learning Cycle Development.